Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tian

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Oncogene|April 23, 2013
ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinomaL Xia, W Huang, D Tian, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chainsB Lagu, D Tian, D Nagarathnam, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine seriesW C Wong, W Sun, B Lagu, et al.
Journal of Medicinal Chemistry|August 24, 2000
De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailabilityB Lagu, D Tian, Y Jeon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2013
Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013A Zhang, Y Huang, D Tian, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 23, 2025
[Clinicopathological features and surgery-related outcomes of duodenal adenocarcinoma: a multicenter retrospective study]Q F Xiao, X Wu, C H Yuan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2016
Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial ParadigmXiangqing Sun, Robert C Elston, Jill S Barnholtz-Sloan, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinonesD Nagarathnam, S W Miao, B Lagu, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moietyT G Murali Dhar, D Nagarathnam, M R Marzabadi, et al.
Molecular Psychiatry|November 6, 2013
Common genetic variants on 1p13.2 associate with risk of autismK Xia, H Guo, Z Hu, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Oncogene|April 23, 2013
ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinomaL Xia, W Huang, D Tian, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 3. Approaches to eliminate opioid agonist metabolites by using substituted phenylpiperazine side chainsB Lagu, D Tian, D Nagarathnam, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine seriesW C Wong, W Sun, B Lagu, et al.
Journal of Medicinal Chemistry|August 24, 2000
De novo design of a novel oxazolidinone analogue as a potent and selective alpha1A adrenergic receptor antagonist with high oral bioavailabilityB Lagu, D Tian, Y Jeon, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|December 18, 2013
Kinetics of serological responses in influenza A(H7N9)-infected patients correlate with clinical outcome in China, 2013A Zhang, Y Huang, D Tian, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 23, 2025
[Clinicopathological features and surgery-related outcomes of duodenal adenocarcinoma: a multicenter retrospective study]Q F Xiao, X Wu, C H Yuan, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 2, 2016
Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial ParadigmXiangqing Sun, Robert C Elston, Jill S Barnholtz-Sloan, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 1. Structure-activity relationship in dihydropyrimidinonesD Nagarathnam, S W Miao, B Lagu, et al.
Journal of Medicinal Chemistry|December 2, 1999
Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 2. Approaches to eliminate opioid agonist metabolites via modification of linker and 4-methoxycarbonyl-4-phenylpiperidine moietyT G Murali Dhar, D Nagarathnam, M R Marzabadi, et al.
Molecular Psychiatry|November 6, 2013
Common genetic variants on 1p13.2 associate with risk of autismK Xia, H Guo, Z Hu, et al.
Pageof 16